Next Article in Journal
Microencapsulation of Purple Cactus Pear Fruit (Opuntia ficus indica) Extract by the Combined Method W/O/W Double Emulsion-Spray Drying and Conventional Spray Drying: A Comparative Study
Next Article in Special Issue
A Newly Designed EGFP-2A Peptide Monocistronic Baculoviral Vector for Concatenating the Expression of Recombinant Proteins in Insect Cells
Previous Article in Journal
A Novel Framework for Parameter and State Estimation of Multicellular Systems Using Gaussian Mixture Approximations

Non-Viral Transfection of Human T Lymphocytes

Process Biotechnology, University of Bayreuth, 95440 Bayreuth, Germany
Agap2—HIQ Consulting GmbH, 60323 Frankfurt am Main, Germany
Department Synthesis of Macromolecules, Max Planck Institute for Polymer Research, 55128 Mainz, Germany
Author to whom correspondence should be addressed.
Processes 2018, 6(10), 188;
Received: 10 September 2018 / Revised: 27 September 2018 / Accepted: 9 October 2018 / Published: 11 October 2018
(This article belongs to the Special Issue Transient Gene Expression for Rapid Protein and Virus-Vector Supply)
The genetic modification of human T lymphocytes with established non-viral methods is inefficient. Linear polyethylenimine (l-PEI), one of the most popular non-viral transfection agents for mammalian cells in general, only achieves transfection rates in the single digit percentage range for these cells. Here, a well-defined 24-armed poly(2-dimethylamino) ethyl methacrylate (PDMAEMA) nanostar (number average of the molecular weight: 755 kDa, polydispersity: <1.21) synthesized via atom transfer radical polymerization (ATRP) from a silsesquioxane initiator core is proposed as alternative. The agent is used to prepare polyplexes with plasmid DNA (pDNA). Under optimal conditions these polyplexes reproducibly transfect >80% of the cells from a human T-cell leukemia cell line (Jurkat cells) at viabilities close to 90%. The agent also promotes pDNA uptake when simply added to a mixture of cells and pDNA. This constitutes a particular promising approach for efficient transient transfection at large scale. Finally, preliminary experiments were carried out with primary T cells from two different donors. Results were again significantly better than for l-PEI, although further research into the response of individual T cells to the transfection agent will be necessary, before either method can be used to routinely transfect primary T lymphocytes. View Full-Text
Keywords: non-viral gene delivery; Jurkat cells; human T lymphocytes; primary cells; poly(2-dimethylamino) ethyl methacrylate; polycation; nanostar non-viral gene delivery; Jurkat cells; human T lymphocytes; primary cells; poly(2-dimethylamino) ethyl methacrylate; polycation; nanostar
Show Figures

Graphical abstract

MDPI and ACS Style

Riedl, S.A.B.; Kaiser, P.; Raup, A.; Synatschke, C.V.; Jérôme, V.; Freitag, R. Non-Viral Transfection of Human T Lymphocytes. Processes 2018, 6, 188.

AMA Style

Riedl SAB, Kaiser P, Raup A, Synatschke CV, Jérôme V, Freitag R. Non-Viral Transfection of Human T Lymphocytes. Processes. 2018; 6(10):188.

Chicago/Turabian Style

Riedl, Simon A.B., Patrick Kaiser, Alexander Raup, Christopher V. Synatschke, Valérie Jérôme, and Ruth Freitag. 2018. "Non-Viral Transfection of Human T Lymphocytes" Processes 6, no. 10: 188.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop